NCT03396068 NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03395392 NRX-101 for Bipolar Depression With Subacute Suicidal Ideation Status COMPLETED Phase PHASE2/PHASE3
NCT03349528 Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03339596 Effects of Erythropoietin for Cognitive Side-effects of ECT Status COMPLETED Phase PHASE2
NCT03336918 Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03310593 Cannabidiol as an Adjunctive Treatment for Bipolar Depression Status TERMINATED Phase PHASE2/PHASE3
NCT03279224 Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder Status UNKNOWN Phase PHASE2/PHASE3
NCT03249376 Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally Status COMPLETED Phase PHASE3
NCT02989727 Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine Status COMPLETED Phase PHASE4
NCT02974010 Sequential Therapy for the Treatment of Severe Bipolar Depression. Status COMPLETED Phase PHASE2
NCT02740244 Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression Status TERMINATED Phase NA
NCT02719392 A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression Status SUSPENDED Phase PHASE4
NCT02703363 Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression Status COMPLETED Phase PHASE3
NCT02600507 Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression Status COMPLETED Phase PHASE3
NCT02600494 Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression Status COMPLETED Phase PHASE3